{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:26:05Z","timestamp":1790745965384,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.breast.2014.12.008","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T06:09:56Z","timestamp":1421906996000},"page":"153-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Fracture incidence in pre- and postmenopausal women after completion of adjuvant hormonal therapy for breast cancer"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1487-1635","authenticated-orcid":false,"given":"C.","family":"Koopal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Janssen-Heijnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"van de Wouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2014.12.008_bib1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2014.12.008_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ejca.2007.12.015","article-title":"Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s","volume":"44","author":"Karim-Kos","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2014.12.008_bib3","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/annonc\/mdt030","article-title":"Cancer prevalence estimates in Europe at the beginning of 2000","volume":"24","author":"Gatta","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2014.12.008_bib4","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Effect of screening and adjuvant therapy on mortality from breast cancer","volume":"353","author":"Berry","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2014.12.008_bib5","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2147\/CIA.S3466","article-title":"Aromatase inhibitors, efficacy and metabolic risk in the treatment of postmenopausal women with early breast cancer","volume":"3","author":"Gonnelli","year":"2008","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.breast.2014.12.008_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ecl.2011.05.008","article-title":"Management of bone disease in patients undergoing hormonal\u00a0therapy for breast cancer","volume":"40","author":"Mirza","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.breast.2014.12.008_bib7","article-title":"Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women","author":"Gibson","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.breast.2014.12.008_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1470-2045(07)70385-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial","volume":"9","author":"Forbes","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2014.12.008_bib9","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa032312","article-title":"A\u00a0randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer","volume":"349","author":"Goss","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2014.12.008_bib10","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0140-6736(07)60200-1","article-title":"Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial","volume":"369","author":"Coombes","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2014.12.008_bib11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1185\/030079907X187919","article-title":"Assessing the risk of bone fracture among postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer","volume":"23","author":"Bell","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.breast.2014.12.008_bib12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.breast.2014.12.008_bib13","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","article-title":"Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial","volume":"11","author":"Cuzick","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2014.12.008_bib14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJMoa0806285","article-title":"Endocrine therapy plus zoledronic acid in premenopausal breast cancer","volume":"360","author":"Gnant","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.breast.2014.12.008_bib15","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1470-2045(11)70122-X","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial","volume":"12","author":"Gnant","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2014.12.008_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"24","author":"Kanis","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.breast.2014.12.008_bib17","series-title":"Dutch guideline osteoporosis and fracture prevention (3rd revision) (richtlijn Osteoporose en fractuurpreventie derde herziening, Centraal Begeleidings Orgaan (CBO))","author":"CBO","year":"2011"},{"key":"10.1016\/j.breast.2014.12.008_bib18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.297.4.387","article-title":"Risk of subsequent fracture after low-trauma fracture in men and women","volume":"297","author":"Center","year":"2007","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.breast.2014.12.008_bib19","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2014.12.008_bib20","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S1470-2045(08)70204-3","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy","volume":"9","author":"Gnant","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2014.12.008_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S8756-3282(01)00614-7","article-title":"Epidemiology of fractures in England and Wales","volume":"29","author":"van Staa","year":"2001","journal-title":"Bone"},{"key":"10.1016\/j.breast.2014.12.008_bib22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1359\/jbmr.081244","article-title":"A\u00a0simple risk score for the assessment of absolute fracture risk in general practice based on two longitudinal studies","volume":"24","author":"Pluijm","year":"2009","journal-title":"J\u00a0bone Mineral Res Official J Am Soc Bone Mineral Res"},{"key":"10.1016\/j.breast.2014.12.008_bib23","series-title":"Osteoporosis (2nd revised guideline) (Osteoporose Tweede herziene richtlijn)","author":"CBO","year":"2002"},{"key":"10.1016\/j.breast.2014.12.008_bib24","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1200\/JCO.2001.19.14.3306","article-title":"Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer","volume":"19","author":"Shapiro","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.breast.2014.12.008_bib25","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00198-003-1508-y","article-title":"Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)","volume":"14","author":"Fogelman","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.breast.2014.12.008_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.breast.2014.12.008_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","article-title":"A\u00a0meta-analysis of previous fracture and subsequent fracture risk","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.breast.2014.12.008_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","article-title":"Smoking and fracture risk: a meta-analysis","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int J Established Result Coop Between Eur Found Osteoporos Natl Osteoporos Found U S A"},{"key":"10.1016\/j.breast.2014.12.008_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int J Established Result Coop Between Eur Found Osteoporos Natl Osteoporos Found U S A"},{"key":"10.1016\/j.breast.2014.12.008_bib30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/1529-0131(200106)44:6<1254::AID-ART216>3.0.CO;2-G","article-title":"Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease","volume":"44","author":"Kroot","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.breast.2014.12.008_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.rmed.2006.03.029","article-title":"The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study","volume":"101","author":"Jorgensen","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.breast.2014.12.008_bib32","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American society of clinical oncology clinical practice guideline focused update","volume":"32","author":"Burstein","year":"2014","journal-title":"J\u00a0Clin Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977614002409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977614002409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:32:09Z","timestamp":1760776329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977614002409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0960977614002409"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2014.12.008","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fracture incidence in pre- and postmenopausal women after completion of adjuvant hormonal therapy for breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2014.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}